REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $692 | -99.9% | 27,345 | -62.0% | 0.01% | -50.0% |
| Q2 2022 | $995,000 | +38.4% | 71,966 | +63.4% | 0.01% | +71.4% |
| Q4 2021 | $719,000 | -18.0% | 44,037 | +39.9% | 0.01% | -41.7% |
| Q3 2021 | $877,000 | -8.3% | 31,472 | -2.4% | 0.01% | +9.1% |
| Q2 2021 | $956,000 | +5.9% | 32,250 | -0.2% | 0.01% | -15.4% |
| Q1 2021 | $903,000 | +92.9% | 32,319 | +95.8% | 0.01% | +160.0% |
| Q4 2020 | $468,000 | -78.3% | 16,507 | -80.7% | 0.01% | -88.4% |
| Q3 2020 | $2,153,000 | +78.5% | 85,659 | +73.4% | 0.04% | +38.7% |
| Q2 2020 | $1,206,000 | +531.4% | 49,396 | +319.9% | 0.03% | +675.0% |
| Q4 2019 | $191,000 | – | 11,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |